Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
Laura Bracci(Istituto Superiore di Sanità), Filippo Belardelli(Istituto Superiore di Sanità)
Cited by 932
Related Papers
Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice
|The Journal of Experimental Medicine|2000|635
Classification of current anticancer immunotherapies
|Oncotarget|2014|469